866-997-4948(US-Canada Toll Free)

Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2015

Published By :

Global Markets Direct

Published Date : Apr 2015

Category :

Cancer

No. of Pages : 25 Pages

Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2015

Summary

Global Markets Directs, Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2015, provides an overview of the Cancer Therapeutics CRC Pty Ltds pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Cancer Therapeutics CRC Pty Ltds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Cancer Therapeutics CRC Pty Ltd including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Cancer Therapeutics CRC Pty Ltds human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Cancer Therapeutics CRC Pty Ltds pipeline products

Reasons to buy

- Evaluate Cancer Therapeutics CRC Pty Ltds strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Cancer Therapeutics CRC Pty Ltd in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Cancer Therapeutics CRC Pty Ltds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Cancer Therapeutics CRC Pty Ltd and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cancer Therapeutics CRC Pty Ltd
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Cancer Therapeutics CRC Pty Ltd and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Cancer Therapeutics CRC Pty Ltd Snapshot 4
Cancer Therapeutics CRC Pty Ltd Overview 4
Key Information 4
Key Facts 4
Cancer Therapeutics CRC Pty Ltd - Research and Development Overview 5
Key Therapeutic Areas 5
Cancer Therapeutics CRC Pty Ltd - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
Pipeline Products - Out-Licensed Products 11
Out-Licensed Products/Combination Treatment Modalities 12
Cancer Therapeutics CRC Pty Ltd - Pipeline Products Glance 13
Cancer Therapeutics CRC Pty Ltd - Early Stage Pipeline Products 13
Discovery Products/Combination Treatment Modalities 13
Cancer Therapeutics CRC Pty Ltd - Drug Profiles 14
Small Molecule Inhibiting Mitosis for Solid Tumors 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Small Molecule to Inhibit USP7 for Cancer 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Small Molecules For Cancer 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Small Molecules to Inhibit MOZ for Acute Myelocytic Leukemia 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Small Molecules to Inhibit Ubiquitin E3 Ligase E6AP for Cancer 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Cancer Therapeutics CRC Pty Ltd - Pipeline Analysis 19
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Target 19
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Molecule Type 20
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Mechanism of Action 21
Cancer Therapeutics CRC Pty Ltd - Dormant Projects 22
Cancer Therapeutics CRC Pty Ltd - Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 24
Disclaimer 25

List of Tables
Cancer Therapeutics CRC Pty Ltd, Key Information 4
Cancer Therapeutics CRC Pty Ltd, Key Facts 4
Cancer Therapeutics CRC Pty Ltd - Pipeline by Indication, 2015 6
Cancer Therapeutics CRC Pty Ltd - Pipeline by Stage of Development, 2015 7
Cancer Therapeutics CRC Pty Ltd - Monotherapy Products in Pipeline, 2015 8
Cancer Therapeutics CRC Pty Ltd - Partnered Products in Pipeline, 2015 9
Cancer Therapeutics CRC Pty Ltd - Partnered Products/ Combination Treatment Modalities, 2015 10
Cancer Therapeutics CRC Pty Ltd - Out-Licensed Products in Pipeline, 2015 11
Cancer Therapeutics CRC Pty Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2015 12
Cancer Therapeutics CRC Pty Ltd - Discovery, 2015 13
Cancer Therapeutics CRC Pty Ltd - Pipeline by Target, 2015 19
Cancer Therapeutics CRC Pty Ltd - Pipeline by Molecule Type, 2015 20
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Mechanism of Action, 2015 21
Cancer Therapeutics CRC Pty Ltd - Dormant Developmental Projects,2015 22

List of Figures
Cancer Therapeutics CRC Pty Ltd - Pipeline by Top 10 Indication, 2015 6
Cancer Therapeutics CRC Pty Ltd - Partnered Products in Pipeline, 2015 9
Cancer Therapeutics CRC Pty Ltd - Pipeline by Top 10 Molecule Type, 2015 20
Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Top 10 Mechanism of Action, 2015 21

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *